UNSPSC 51453012: Piperazine hydrate

This classification denotes an antihelminthic agent with the molecular formula C4H10N2.6H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P3M07B8U64, chemically known as 1,4-piperazine but more generally known as piperazine hydrate, which bears US NIH Compound Identifier 4837. European Medicines Agency schedules Piperazine hydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12218MIG. Most nations, for tariff and trade purposes, schedule piperazine hydrate under HS 29335990.

As of Q4 2014, PIPERAZINE HYDRATE remains US FDA's Preferred Term for this commodity. SMILES: C1CNCCN1.O.

UNSPSC 51453012 Piperazine hydrate, a Commodity code, covers pharmaceutical active ingredients and chemical compounds used in drug manufacturing and public health supply chains. State and local governments procure under this code primarily through pharmaceutical warehouse contracts and health department supply agreements that bundle active pharmaceutical ingredients with finished goods. The issuing bodies soliciting under the code include state health departments and county health authorities that source pharmaceuticals for emergency preparedness, disease treatment programs, and community health initiatives. These jurisdictions typically use cooperative purchasing vehicles and piggyback contracts to consolidate pharmaceutical procurement across multiple agencies and reduce costs through volume discounting.

Recent activity shows the Illinois Department of Public Health and Seminole County, Florida as active buyers. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract to Chartwell Rx LLC through the MMCAP Infuse consortium on August 28, 2026 (IFB 26482DPHPREPDB53392), covering antibiotic pharmaceuticals with a total award value of $2,999,999.11 across a 12-month initial term plus two renewal options. Seminole County, Florida released an IFB (IFB60459723LAS) on June 30, 2026 for procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries and a two-year initial term plus one-year renewal option. Geographic activity is concentrated in the South and Midwest, with recent solicitations emerging from Florida and Illinois. State health departments and county community health offices remain the primary buyers under this code.